NLRC5 potentiates anti-tumor CD8+T cells responses by activating interferon-β in endometrial cancer
- Resource Type
- Article
- Authors
- Zhang, Jing; Guo, Bao; Chen, Jia-Hua; Liu, Xiao-Jing; Zhang, Jun-Hui; Zhu, Hai-Qing; Wang, Wen-Yan; Tang, Zhen-Hai; Wei, Bing; Cao, Yun-Xia; Zhan, Lei
- Source
- Translational Oncology; October 2023, Vol. 36 Issue: 1
- Subject
- Language
- ISSN
- 19447124; 19365233
•NLRC5 potentiates antitumor responses of CD8+T cells against EC.•IFN-β promotes immunosurveillance of EC by activating CD8+T cells.•NLRC5 potentiates antitumor responses of CD8+T cells to EC by activating IFN-β.